Point of Care Molecular Diagnostics Market Product, Application, Technology, End User and Top Companies are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Danaher Corporation (US), Quidel Corporation (US), QIAG

The Point of Care Molecular Diagnostics Market research report provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets. It also offers in-depth examination about new product launches, recent developments, untapped geographies, and recent developments. Moreover, the Point of Care Molecular Diagnostics Market report also provides intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The Point of Care Molecular Diagnostics Market research report presents a comprehensive overview, market shares, and growth opportunities by product type, application, key manufacturers, and key regions and countries. The Point of Care Molecular Diagnostics Market report helps to gain insightful analyses of the market and comprehensively understand the global market and its commercial landscape.

Request for FREE Sample Report: To Know the Impact of COVID-19 on this Industry at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=1516295

The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) - Global Forecast to 2026

Lists of Companies Profiled in the Report:

Abbott Laboratories (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
bioMérieux SA (France)
Danaher Corporation (US)
Quidel Corporation (US)
QIAGEN N.V. (Netherlands)
Co-Diagnostics, Inc. (US)
Biocartis NV (Belgium)
Meridian Bioscience, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Lucira Health, Inc. (US)
Cue Health (US)
OpGen, Inc. (US)
Binx Health, Inc. (US)
Molbio Diagnostics Pct. Ltd. (India)
Genomadix (Canada)
Visby Medical, Inc. (US)
QuikPath PTE Ltd. (Singapore)
MD-Bio (US)
QuantuMDx Group Ltd. (UK)
Aidian Oy (Finland)
GeneSTAT Molecular Diagnostics, LLC (US).

The Point of Care Molecular Diagnostics Market report provides comprehensive insights into market valuations, sales, market forecasts, and market shares. In addition, this research analyzes and forecasts market size and sales. Moreover, the report also provides the latest developments in the market.

The primary interviews conducted for this report can be categorized as follows:

By Company Type: Tier 1 - 40%, Tier 2 - 30%,and Tier 3 -30%
By Designation: C-level - 27%, D-level - 18%, and Others - 55%
By Region: North America -51%, Europe - 21%, Asia Pacific - 18% and the Rest of the World - 10%

Market growth is driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests. On the other hand, stringent and time-consuming regulatory policies that significantly increase the product launch cycle may challenge market growth post their commercialization.

"The assays& kits accounted for the highest growth rate in the point-of-care molecular diagnostics market, byproduct& service, during the forecast period"

The point-of-care molecular diagnostics market is segmented into assays & kits, instruments & analyzers and software and services. The assays & kits segment accounted for the highest growth rate in the point-of-care molecular diagnostics market in 2020. The requirement assays& kits in large numbers compared to instruments is the main factor contributing to this segment's high growth rate. This segment's market growth can also be attributed to repeat purchases of assays& kits compared to instruments.

"Sexually transmitted diseases segment accounted for the highest CAGR"

Based on applications, the point-of-care molecular diagnostics market is segmented into respiratory diseases, sexually transmitted diseases, hospital-acquired infections, cancer, hepatitis, gastrointestinal disorders, and other applications. In 2020, the sexually transmitted diseases segment accounted for the highest growth rate. The increasing prevalence of CT/NG infections, HPV, HIV, and Trichomonas vaginalis and technological advancements are major factors driving the growth of this market segment.

"Hospitals & ICUs segment accounted for the highest CAGR"

Based on end users, the market is segmented into physicians' offices, hospitals & ICUs, research institutes, and other end users. In 2020, the hospitals & ICUs segment accounted for the highest growth rate. This can be attributed to the increasing number of hospitals and high demand for diagnostic products in hospitals.

"North America: The fastest-growing region point-of-care molecular diagnostics market"

The global point-of-care molecular diagnostics market is segmented into North America, Europe, Asia Pacific and the Rest of the World. North America accounted for the largest share of the global point-of-care molecular diagnostics market. Factors such as the highly developed healthcare system in the US and Canada and the easy accessibility to technologically advanced instruments are driving the growth of the point-of-care molecular diagnostics market in this region.

Reasons for Buying this Point of Care Molecular Diagnostics Market Report

1. This Point of Care Molecular Diagnostics Market report provides pin-point analysis for changing competitive dynamics

2. It provides a forward-looking perspective on different factors driving or restraining market growth

3. It provides a six-year forecast assessed on the basis of how the market is predicted to grow

4. It helps in understanding the key product segments and their future

5. It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

6. It helps in making informed business decisions by having complete insights of the market and by making in-depth analyses of market segments.

Direct Purchase of Point of Care Molecular Diagnostics Market Research Report at: https://www.reportsnreports.com/purchase.aspx?name=1516295

Contact Us:
Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.